Skip to main content
FinSpry Logo
FinSpry
KYTX logo
KYTX
(NASDAQ)
Kyverna Therapeutics, Inc.
$8.87-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Kyverna Therapeutics (KYTX) Stock Price & Financial Analysis

Kyverna Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.50 - $9.18
52-Week High$13.67
52-Week Low$1.78
Open$8.57
Volume753.80K
Average Volume (3M)753.80K
Market Cap385.09M
Shares Outstanding43.42M
Price to Book (P/B)2.51
EV/EBITDA-2.21
50-Day MA$8.29
200-Day MA$6.40
52-Week Change342.93%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Kyverna Therapeutics

What is the current stock price for KYTX?

As of the latest trading session, KYTX stock trades at $8.87. The 52-week range is $1.78–$13.67, with a day range of $8.50–$9.18.

What is the P/E ratio for KYTX?

The P/E ratio (Price-to-Earnings) for KYTX is shown in the Key Statistics section. This valuation metric helps compare Kyverna Therapeutics, Inc. to industry peers.

Does KYTX pay dividends?

Kyverna Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KYTX?

Analyst ratings and recommendations for KYTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of KYTX?

Kyverna Therapeutics's market capitalization is $385.1M, classifying it as a small-cap company. Kyverna Therapeutics operates in the Healthcare sector within the Biotechnology industry.